← Open Payments lookup

BRIAN WEBER: Open Payments

NPI 1255313763 · COMMERCE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$901 in 49 payments from 18 companies in 2025. Trend: 2023 $983 · 2024 $1,081 · 2025 $901

Food & beverage: $901
CompanyPaymentsAmount
ABBVIE INC.10$220
GlaxoSmithKline, LLC.10$154
Teva Pharmaceuticals USA, Inc.4$75
PFIZER INC.3$75
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$70
Novo Nordisk Inc3$53
ABIOMED1$39
Otsuka America Pharmaceutical, Inc.2$38
AstraZeneca Pharmaceuticals LP2$30
Viatris Specialty LLC1$20

Products named: VRAYLAR, TRELEGY ELLIPTA, AUSTEDO XR, ELIQUIS, CAPLYTA, LINZESS, REXULTI, YUPELRI.

Industry payments across TX — which companies pay providers there.